Abstract Severe asthma (SA) affects approximately 10% of the global asthma population. Symptoms and exacerbations lead to reduced quality of life and increased hospitalisations. Patients with uncontrolled disease often experience increased risks due to delays in referral, assessment, and treatment initiation. The aim of this study was to establish multinational consensus on the preferred approach to time-clocked care in the management of SA from primary through to specialist care.
